PubMed

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.

Treon SP, Branagan AR, Ioakimidis L, Soumerai JD, Patterson CJ, Turnbull B, Wasi P, Emmanouilides C, Frankel SR, Lister A, Morel P, Matous J, Gregory SA, Kimby E.

Blood. 2009 Apr 16;113(16):3673-8. Epub 2008 Nov 17.PMID: 19015393 [PubMed - indexed for MEDLINE]Related articles

Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.

Fantin VR, Loboda A, Paweletz CP, Hendrickson RC, Pierce JW, Roth JA, Li L, Gooden F, Korenchuk S, Hou XS, Harrington EA, Randolph S, Reilly JF, Ware CM, Kadin ME, Frankel SR, Richon VM.

Cancer Res. 2008 May 15;68(10):3785-94.PMID: 18483262 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.

Crump M, Coiffier B, Jacobsen ED, Sun L, Ricker JL, Xie H, Frankel SR, Randolph SS, Cheson BD.

Ann Oncol. 2008 May;19(5):964-9. Epub 2008 Feb 21.PMID: 18296419 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.

Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda WG, Faderl S, Koller C, Morris G, Rosner G, Loboda A, Fantin VR, Randolph SS, Hardwick JS, Reilly JF, Chen C, Ricker JL, Secrist JP, Richon VM, Frankel SR, Kantarjian HM.

Blood. 2008 Feb 1;111(3):1060-6. Epub 2007 Oct 25.PMID: 17962510 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.

Blumenschein GR Jr, Kies MS, Papadimitrakopoulou VA, Lu C, Kumar AJ, Ricker JL, Chiao JH, Chen C, Frankel SR.

Invest New Drugs. 2008 Feb;26(1):81-7. Epub 2007 Oct 25.PMID: 17960324 [PubMed - indexed for MEDLINE]Related articles

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, Frankel SR, Chen C, Ricker JL, Arduino JM, Duvic M.

J Clin Oncol. 2007 Jul 20;25(21):3109-15. Epub 2007 Jun 18.PMID: 17577020 [PubMed - indexed for MEDLINE]Related articles

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.

Wetzler M, Sanford BL, Kurtzberg J, DeOliveira D, Frankel SR, Powell BL, Kolitz JE, Bloomfield CD, Larson RA.

Blood. 2007 May 15;109(10):4164-7. Epub 2007 Jan 30.PMID: 17264295 [PubMed - indexed for MEDLINE]Related articlesFree article

A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer.

Rubin EH, Agrawal NG, Friedman EJ, Scott P, Mazina KE, Sun L, Du L, Ricker JL, Frankel SR, Gottesdiener KM, Wagner JA, Iwamoto M.

Clin Cancer Res. 2006 Dec 1;12(23):7039-45.PMID: 17145826 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR.

Blood. 2007 Jan 1;109(1):31-9. Epub 2006 Sep 7. Erratum in: Blood. 2007 Jun 15;109(12):5086. PMID: 16960145 [PubMed - indexed for MEDLINE]Related articlesFree article

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM.

Biol Blood Marrow Transplant. 2006 Feb;12(2):204-16.PMID: 16443518 [PubMed - indexed for MEDLINE]Related articles

Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

Feldman EJ, Brandwein J, Stone R, Kalaycio M, Moore J, O'Connor J, Wedel N, Roboz GJ, Miller C, Chopra R, Jurcic JC, Brown R, Ehmann WC, Schulman P, Frankel SR, De Angelo D, Scheinberg D.

J Clin Oncol. 2005 Jun 20;23(18):4110-6.PMID: 15961759 [PubMed - indexed for MEDLINE]Related articles

A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer.

Tolcher AW, Chi K, Kuhn J, Gleave M, Patnaik A, Takimoto C, Schwartz G, Thompson I, Berg K, D'Aloisio S, Murray N, Frankel SR, Izbicka E, Rowinsky E.

Clin Cancer Res. 2005 May 15;11(10):3854-61.PMID: 15897586 [PubMed - indexed for MEDLINE]Related articlesFree article

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

Treon SP, Hansen M, Branagan AR, Verselis S, Emmanouilides C, Kimby E, Frankel SR, Touroutoglou N, Turnbull B, Anderson KC, Maloney DG, Fox EA.

J Clin Oncol. 2005 Jan 20;23(3):474-81.PMID: 15659493 [PubMed - indexed for MEDLINE]Related articles

Extended rituximab therapy in Waldenström's macroglobulinemia.

Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR; Waldenström's Macroglobulinemia Clinical Trials Group.

Ann Oncol. 2005 Jan;16(1):132-8.PMID: 15598950 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.

Marshall J, Chen H, Yang D, Figueira M, Bouker KB, Ling Y, Lippman M, Frankel SR, Hayes DF.

Ann Oncol. 2004 Aug;15(8):1274-83.PMID: 15277270 [PubMed - indexed for MEDLINE]Related articlesFree article

Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer.

Herbst RS, Frankel SR.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4245s-4248s. Review.PMID: 15217967 [PubMed - indexed for MEDLINE]Related articlesFree article

G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma.

van de Donk NW, de Weerdt O, Veth G, Eurelings M, van Stralen E, Frankel SR, Hagenbeek A, Bloem AC, Lokhorst HM.

Leukemia. 2004 Jun;18(6):1078-84.PMID: 15085157 [PubMed - indexed for MEDLINE]Related articles

Oblimersen sodium (G3139 Bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: a targeted approach to enhance apoptosis.

Frankel SR.

Semin Oncol. 2003 Apr;30(2):300-4. Review.PMID: 12720157 [PubMed - indexed for MEDLINE]Related articles

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP.

Semin Oncol. 2003 Apr;30(2):121-6. Review.PMID: 12720120 [PubMed - indexed for MEDLINE]Related articles

Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.

Weiss MA, Maslak PG, Jurcic JG, Scheinberg DA, Aliff TB, Lamanna N, Frankel SR, Kossman SE, Horgan D.

J Clin Oncol. 2003 Apr 1;21(7):1278-84.PMID: 12663715 [PubMed - indexed for MEDLINE]Related articles

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

Szatrowski TP, Dodge RK, Reynolds C, Westbrook CA, Frankel SR, Sklar J, Stewart CC, Hurd DD, Kolitz JE, Velez-Garcia E, Stone RM, Bloomfield CD, Schiffer CA, Larson RA.

Cancer. 2003 Mar 15;97(6):1471-80.PMID: 12627512 [PubMed - indexed for MEDLINE]Related articlesFree article

The power and perils of prediction.

Frankel SR.

Cancer J. 2003 Jan-Feb;9(1):28-30. Review. No abstract available. PMID: 12602764 [PubMed - indexed for MEDLINE]Related articles

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

Marcucci G, Byrd JC, Dai G, Klisovic MI, Kourlas PJ, Young DC, Cataland SR, Fisher DB, Lucas D, Chan KK, Porcu P, Lin ZP, Farag SF, Frankel SR, Zwiebel JA, Kraut EH, Balcerzak SP, Bloomfield CD, Grever MR, Caligiuri MA.

Blood. 2003 Jan 15;101(2):425-32. Epub 2002 Aug 22.PMID: 12393493 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature.

Truica CI, Frankel SR.

Am J Hematol. 2002 Aug;70(4):320-3. Review.PMID: 12210815 [PubMed - indexed for MEDLINE]Related articles

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.

Weiss MA, Aliff TB, Tallman MS, Frankel SR, Kalaycio ME, Maslak PG, Jurcic JG, Scheinberg DA, Roma TE.

Cancer. 2002 Aug 1;95(3):581-7.PMID: 12209751 [PubMed - indexed for MEDLINE]Related articlesFree article

Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.

Klasa RJ, Gillum AM, Klem RE, Frankel SR.

Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):193-213. Review.PMID: 12162702 [PubMed - indexed for MEDLINE]Related articles

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.

Rapoport AP, Meisenberg B, Sarkodee-Adoo C, Fassas A, Frankel SR, Mookerjee B, Takebe N, Fenton R, Heyman M, Badros A, Kennedy A, Jacobs M, Hudes R, Ruehle K, Smith R, Kight L, Chambers S, MacFadden M, Cottler-Fox M, Chen T, Phillips G, Tricot G.

Bone Marrow Transplant. 2002 Feb;29(4):303-12.PMID: 11896427 [PubMed - indexed for MEDLINE]Related articlesFree article

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutré S, Dahlberg S, Ellison R, Warrell RP Jr.

J Clin Oncol. 2001 Sep 15;19(18):3852-60.PMID: 11559723 [PubMed - indexed for MEDLINE]Related articles

Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

Oliverio PJ, Restrepo L, Mitchell SA, Tornatore CS, Frankel SR.

AJNR Am J Neuroradiol. 2000 Aug;21(7):1251-4.PMID: 10954277 [PubMed - indexed for MEDLINE]Related articlesFree article

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.

Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J.

Bone Marrow Transplant. 2000 Jul;26(2):203-10.PMID: 10918432 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

Fehniger TA, Bluman EM, Porter MM, Mrózek E, Cooper MA, VanDeusen JB, Frankel SR, Stock W, Caligiuri MA.

J Clin Invest. 2000 Jul;106(1):117-24.PMID: 10880055 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.

Wetzler M, Dodge RK, Mrózek K, Carroll AJ, Tantravahi R, Block AW, Pettenati MJ, Le Beau MM, Frankel SR, Stewart CC, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD.

Blood. 1999 Jun 1;93(11):3983-93.PMID: 10339508 [PubMed - indexed for MEDLINE]Related articlesFree article

Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Davey FR, Powell BL, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD.

Blood. 1999 Jun 1;93(11):3931-9.PMID: 10339502 [PubMed - indexed for MEDLINE]Related articlesFree article

Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.

Arun B, Berberian B, Azumi N, Frankel SR, Luksenburg H, Freter C.

Leuk Lymphoma. 1998 Nov;31(5-6):613-5.PMID: 9922053 [PubMed - indexed for MEDLINE]Related articles

Current approaches to acute promyelocytic leukemia.

Frankel SR, Powell BL.

Cancer Treat Res. 1999;99:125-53. Review. No abstract available. PMID: 9891865 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.

Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA.

Blood. 1998 Sep 1;92(5):1556-64.PMID: 9716583 [PubMed - indexed for MEDLINE]Related articlesFree article

A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies.

Meehan KR, Badros A, Frankel SR, Cahill R, Areman E, Jenson M, Sacher R, Mazumder A.

J Hematother. 1997 Oct;6(5):457-64.PMID: 9368182 [PubMed - indexed for MEDLINE]Related articles

Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.

Vyas RC, Frankel SR, Agbor P, Miller WH Jr, Warrell RP Jr, Hittelman WN.

Blood. 1996 Jan 1;87(1):218-26.PMID: 8547645 [PubMed - indexed for MEDLINE]Related articlesFree article

A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al.

Blood. 1995 Apr 15;85(8):2025-37.PMID: 7718875 [PubMed - indexed for MEDLINE]Related articlesFree article

Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762)

Stock W, Westbrook CA, Sher DA, Dodge R, Sobol RE, Wurster-Hill D, Davey FR, Larson RA, LeBeau MM, Aplan PD, Frankel SR, Stewart CC, Bloomfield CD.

Clin Cancer Res. 1995 Apr;1(4):459-63.PMID: 9816004 [PubMed - as supplied by publisher]Related articlesFree article

Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.

Warrell RP Jr, Maslak P, Eardley A, Heller G, Miller WH Jr, Frankel SR.

Leukemia. 1994 Jun;8(6):929-33.PMID: 8207986 [PubMed - indexed for MEDLINE]Related articles

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.

Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrovsky E, Warrell RP Jr.

Ann Intern Med. 1994 Feb 15;120(4):278-86.PMID: 8291820 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.

Caligiuri MA, Schichman SA, Strout MP, Mrózek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD.

Cancer Res. 1994 Jan 15;54(2):370-3.PMID: 8275471 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience.

Warrell RP Jr, Maslak P, Eardley A, Heller G, Miller WH Jr, Frankel SR.

Leukemia. 1994;8 Suppl 2:S33-7.PMID: 7815834 [PubMed - indexed for MEDLINE]Related articles

High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.

Baer MR, Christiansen NP, Frankel SR, Brunetto VL, Mrózek K, Bloomfield CD, Herzig GP.

Semin Oncol. 1993 Dec;20(6 Suppl 8):6-12.PMID: 7507264 [PubMed - indexed for MEDLINE]Related articles

Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.

Miller WH Jr, Levine K, DeBlasio A, Frankel SR, Dmitrovsky E, Warrell RP Jr.

Blood. 1993 Sep 15;82(6):1689-94.PMID: 8400225 [PubMed - indexed for MEDLINE]Related articlesFree article

Neutrophil function following therapy for APL.

Frankel SR.

Leukemia. 1993 Sep;7(9):1478-9. No abstract available. PMID: 8371599 [PubMed - indexed for MEDLINE]Related articles

Acute promyelocytic leukemia. New insights into diagnosis and therapy.

Frankel SR.

Hematol Oncol Clin North Am. 1993 Feb;7(1):109-38. Review.PMID: 8449855 [PubMed - indexed for MEDLINE]Related articles

Correction: location of bcl-2 oncogene.

Frankel SR.

N Engl J Med. 1993 Jan 14;328(2):141. No abstract available. PMID: 8416434 [PubMed - indexed for MEDLINE]Related articles

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex.

Corr M, Boyd LF, Frankel SR, Kozlowski S, Padlan EA, Margulies DH.

J Exp Med. 1992 Dec 1;176(6):1681-92.PMID: 1281216 [PubMed - indexed for MEDLINE]Related articlesFree article